Interventional Oncology Devices – Market Insights – Latin America

Despite the short-term challenges posed by the COVID-19 pandemic, the Latin America interventional oncology device market will see moderate growth through 2031 driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of new competitors. However, a lack of reimbursement and pricing pressures will remain a challenge.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in the Latin America region from 2019 through 2031.

The COVID-19 pandemic had a relatively limited impact on the Latin American interventional oncology device market.

To what extent did COVID-19 affect the different procedure types in the interventional oncology device market?

How will procedure volume recover over the forecast period?

The ablation device market is dominated by RF ablation; however, new technologies are increasingly being used.

What are the advantages and disadvantages of each type of ablation device, and how do these differences affect adoption for different indications?

What is the current status of device availability in the geographies covered?

How does the uptake of microwave ablation devices affect other types of ablation devices, like RF ablation devices, and how are competitors preparing for this shift?

The launch of new products will drive the growth of Latin American interventional oncology device market.

What new products are anticipated to be launched in Latin America?

What product features are companies focusing on during novel product development?